Eli Lilly stock surges after company touts strong sales outlook as rival Novo Nordisk continues plunge

view original post

The rally in Lilly also pressured shares of its main weight-loss rival, Danish drugmaker Novo Nordisk ( NVO ), for a second straight day. Novo stock fell as much as 6% in afternoon trade on Wednesday.